Abstract
In recent years, medicinal chemists have begun to realize that dendrimers may be a keystone in the future of medicine. The field of oncology will soon be revolutionized by novel strategies for diagnosis and therapy employing dendrimer-based nanodevices. In the near future, cancer diagnosis via MRI will be improved by the incorporation of dendrimers as advanced contrast agents. Novel dendrimer-based contrast agents can not only be targeted specifically to cancer cells but may also incorporate a cytotoxic function to induce apoptosis on said cells as well. Dendrimers are being applied to a variety of cancer therapies to improve the safety and effectiveness of many common therapeutics. Investigations into the applicability of dendrimers in photodynamic therapy, boron neutron capture therapy, and gene transfection are also being undertaken. This review will cover the fundamentals of cutting-edge research utilizing dendrimers for cancer diagnosis and therapy. An objective review of these new technologies will detail how dendrimerbased nanodevices are advantageous over conventional medicine.
Keywords: PAMAM dendrimer, drug delivery, cancer diagnosis, cancer therapy, chemotherapy, photodynamic therapy, MRI, apoptosis
Current Topics in Medicinal Chemistry
Title: Current Dendrimer Applications in Cancer Diagnosis and Therapy
Volume: 8 Issue: 14
Author(s): Istvan J. Majoros, Christopher R. Williams and James R. Baker Jr.
Affiliation:
Keywords: PAMAM dendrimer, drug delivery, cancer diagnosis, cancer therapy, chemotherapy, photodynamic therapy, MRI, apoptosis
Abstract: In recent years, medicinal chemists have begun to realize that dendrimers may be a keystone in the future of medicine. The field of oncology will soon be revolutionized by novel strategies for diagnosis and therapy employing dendrimer-based nanodevices. In the near future, cancer diagnosis via MRI will be improved by the incorporation of dendrimers as advanced contrast agents. Novel dendrimer-based contrast agents can not only be targeted specifically to cancer cells but may also incorporate a cytotoxic function to induce apoptosis on said cells as well. Dendrimers are being applied to a variety of cancer therapies to improve the safety and effectiveness of many common therapeutics. Investigations into the applicability of dendrimers in photodynamic therapy, boron neutron capture therapy, and gene transfection are also being undertaken. This review will cover the fundamentals of cutting-edge research utilizing dendrimers for cancer diagnosis and therapy. An objective review of these new technologies will detail how dendrimerbased nanodevices are advantageous over conventional medicine.
Export Options
About this article
Cite this article as:
Majoros J. Istvan, Williams R. Christopher and Baker Jr. R. James, Current Dendrimer Applications in Cancer Diagnosis and Therapy, Current Topics in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/156802608785849049
DOI https://dx.doi.org/10.2174/156802608785849049 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Apoptosis Pathways and Neuroblastoma Therapy
Current Pharmaceutical Design 5-HT5 Receptors
Current Drug Targets - CNS & Neurological Disorders Adaptor Protein 3BP2 and Cherubism
Current Medicinal Chemistry In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles
Current Pharmaceutical Biotechnology Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Meet Our Co-Editor
Current Signal Transduction Therapy Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to Accelerate Drug Development
Current Pharmaceutical Design Toll-Like Receptors: Cost or Benefit for Cancer?
Current Pharmaceutical Design Recent Trend for EGFR-Based and ALK-Based Targets: A Patent Analysis
Recent Patents on Anti-Cancer Drug Discovery New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Current Pharmaceutical Design Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections
Current Drug Metabolism Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents
Current Medicinal Chemistry Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?
Mini-Reviews in Medicinal Chemistry Interleukin-7: a key Mediator in T Cell-driven Autoimmunity, Inflammation, and Tissue Destruction
Current Pharmaceutical Design Recent Developments in Targeting Bromodomain and Extra Terminal Domain Proteins for Cancer Therapeutics
Current Medicinal Chemistry Application of NMR to the Study of Cells and Body Fluids
Current Organic Chemistry Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design